Cargando…
Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics
OBJECTIVES: Post-hoc analyses have shown an increase incidence of fractures among type 2 diabetes (T2DM) patients treated with thiazolidinediones (TZDs). The mechanisms by which TZDs may be associated with increased fracture risk is not well understood. This article describes the study design and ba...
Autores principales: | Fitzpatrick, Lorraine A., Bilezikian, John P., Wooddell, Margaret, Paul, Gitanjali, Kolatkar, Nikheel S., Nino, Antonio J., Miller, Colin G., Bogado, Cesar E., Arnaud, Claude D., Cobitz, Alexander R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980730/ https://www.ncbi.nlm.nih.gov/pubmed/27536422 http://dx.doi.org/10.3109/21556660.2011.641703 |
Ejemplares similares
-
Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history)
por: García-García, Héctor M., et al.
Publicado: (2011) -
The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data
por: Dunkley, Alison J, et al.
Publicado: (2011) -
Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016) -
An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
por: Cizman, Borut, et al.
Publicado: (2018) -
Controversies in the treatment of postmenopausal osteoporosis: How long to treat with bisphosphonates?
por: Bandeira, Francisco, et al.
Publicado: (2020)